West Pharmaceutical Services, Inc. which gives innovative solutions for injectable drug administration recently announced that it will deliver a presentation on best practices for improving patient outcomes through integrated containment and delivery systems on June 1, 2017 at the 6th Annual InnoPack Pharma Confex in Mumbai.

West’s presentation 2017 will include scientific seminars in Bangalore and Hyderabad and in-house educational workshops with pharmaceutical and biotechnology customers in Ahmedabad, in addition to its presentation at InnoPack Pharma Confex in Mumbai. 

Troy Player, Vice President and Managing Director, Asia Pacific, West Pharmaceutical Service said, “Biosimilars are one of the fast-growing segments in India and fill an important need for advanced and affordable targeted therapies. These sophisticated, and often sensitive molecules, also present unique challenges in drug containment and delivery.”

“For years, West has worked by the side of its customers in India and around the world to help bring biologics, biosimilars and other innovative injectable therapies to patients. We look forward to sharing our scientific insights with biopharmaceutical manufacturers throughout India as part of West’s Biopharma Week 2017.” he added

Graham Reynolds, vice president and general manager, Global Biologics, West Pharmaceutical Services will deliver a presentation on trends in the market and improving patient experiences through optimized biologic drug delivery systems.

This presentation will discuss trends in biologic drug delivery, including the transition to biosimilars, key factors to consider when selecting a containment and delivery system and best practices for improving patient outcomes through integrated containment and delivery solutions.

Additionally, West will also showcase several innovative drug delivery system and packaging component technologies including:

SmartDose platform—a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.

SelfDose patient controlled injector which is an off-the-shelf delivery system that is ergonomically designed for optimal patient administration.